Reaction

Cerebral Artery Thrombosis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 510 reports · 21 co-occurring drugs

As of the last recalculation, Cerebral Artery Thrombosis appears in 510 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is SALMETEROL XINAFOATE (PRR 239.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Salmeterol Xinafoate46239.3240.6
Instalax Polyethylene Glycol 33502690.190.3
Polyethylene Glycol 4002688.188.3
Esomeprazole Magnesium Capsule, Delayed Release2677.077.1
Esomeprazole Magnesium Delayed Release Capsules2677.077.1
Esomeprazole Magnesium Dihydrate2676.776.8
Polyethylene Glycol1662.262.3
Clobazam3460.860.9
0Xygen4641.841.8
Oxygen4641.841.8
Febuxostat Tablets 40 Mg1040.941.0
Febuxostat Tablets 80 Mg1040.941.0
Bleomycin Sulfate936.236.2
Propranolol Hydrochloride4829.929.9
Drospirenone And Ethinyl Estradiol3029.429.4
Busulfan1129.129.2
Tranexamic Acid627.827.9
Alteplase1027.727.7
Febuxostat1024.824.8
Etonogestrel And Ethinyl Estradiol1018.818.8
Romiplostim513.713.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.